A similar concept was observed in a lung cancer study, which reported that coordinated increased in oxidative metabolism, indicated by markers such as PDH, combined with enhanced glycolysis via LDH signaling are associated with worse clinical outcomes [48]. This evidence concerns the gene PDP1 and lung carcinoma.